← SynDRA
DALTROBAN
SynDRA canonical compound SYN0003072 — structure-anchored drug synonym record
| Clinical phase | Phase 3 |
|---|
| Primary target(s) | TBXA2R |
|---|
| Mechanism of action | thromboxane receptor antagonist |
|---|
All known targets
Mechanisms of action (all sources)
- TBXA2R ANTAGONIST
- thromboxane receptor antagonist
- TBXA2R INHIBITOR
Bioactivity evidence (ChEMBL activities table — not curator-asserted)
- ABL1
- AURKA
- BRD4
- BRPF1
- CDK2
- CSNK1D
- FGFR3
- GSK3B
- HDAC6
- MAPK1
- TRIM24
Screening evidence (raw PubChem HTS — uncurated, known false-positive rate)
Drug classes
- Immunosuppressive Agents
- Platelet Aggregation Inhibitors
Cross-references
Synonyms
- BM 13.505
- BM-13505
- BM13505
- SK&F 96148
- SKF-96148
- SKF96148
- BM 13505
- Daltrobanum
- UNII-S25VDY08ZC
- C16H16ClNO4S
- F-96148
- S25VDY08ZC
- CHEMBL71685
- 4-(2-(4-Chlorophenylsulfonylamino)ethyl)phenylacetic acid
- 4-(2-(4-Chlorobenzenesulfonylamino)ethyl)benzeneacetic acid
- NCGC00165787-02
- 2-(4-(2-(4-chlorophenylsulfonamido)ethyl)phenyl)acetic acid
- 2-[4-[2-[(4-chlorophenyl)sulfonylamino]ethyl]phenyl]acetic acid
- DSSTox_RID_81670
- DSSTox_CID_26501
- DSSTox_GSID_46501
- Benzeneacetic acid, 4-(2-((
- SKF 96148
- SK&F-96148
- DTXCID4026501
- RefChem:585160
- (p-(2-(p-Chlorobenzenesulfonamido)ethyl)phenyl)acetic acid
- BM-13505;SKF 96148
- CAS-79094-20-5
- Daltrobanum [Latin]
- Daltroban [USAN:INN]
- 4-[2-[(4-Chlorophenylsulfonyl)amino]ethyl]benzeneacetic acid
- DALTROBAN [INN]
- DALTROBAN [MI]
- BM 13,505
- Daltroban (USAN/INN)
- DALTROBAN [USAN]
- MLS004712052
Look up DALTROBAN in the interactive SynDRA portal →